NASDAQ:CDXS

Codexis News Headlines

$22.38
-0.82 (-3.53 %)
(As of 04/20/2021 02:27 PM ET)
Add
Compare
Today's Range
$22.00
Now: $22.38▼
$23.17
50-Day Range
$18.08
MA: $22.18▼
$25.46
52-Week Range
$10.28
Now: $22.38▼
$29.56
Volume16,717 shs
Average Volume697,802 shs
Market Capitalization$1.44 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.17

Headlines

Codexis (NASDAQ CDXS) News Headlines Today

SourceHeadline
Codexis (NASDAQ:CDXS) Shares Gap Down to $23.20Codexis (NASDAQ:CDXS) Shares Gap Down to $23.20
americanbankingnews.com - April 20 at 12:50 PM
Codexis (NASDAQ:CDXS) Now Covered by Analysts at Piper SandlerCodexis (NASDAQ:CDXS) Now Covered by Analysts at Piper Sandler
americanbankingnews.com - April 19 at 8:49 AM
Printable DNA “Ink” Just Took A Big Step Forward - ForbesPrintable DNA “Ink” Just Took A Big Step Forward - Forbes
forbes.com - April 15 at 7:29 PM
CSG Systems International (NASDAQ:CSGS) Will Will Want To Turn Around Its Return Trends - NasdaqCSG Systems International (NASDAQ:CSGS) Will Will Want To Turn Around Its Return Trends - Nasdaq
nasdaq.com - April 14 at 9:48 AM
Heres Why Were Not Too Worried About Codexis (NASDAQ:CDXS) Cash Burn Situation - NasdaqHere's Why We're Not Too Worried About Codexis' (NASDAQ:CDXS) Cash Burn Situation - Nasdaq
nasdaq.com - April 14 at 9:48 AM
UPDATE: Piper Sandler Starts Codexis, Inc. (CDXS) at Overweight - StreetInsider.comUPDATE: Piper Sandler Starts Codexis, Inc. (CDXS) at Overweight - StreetInsider.com
streetinsider.com - April 12 at 12:52 PM
Codexis (NASDAQ:CDXS) Shares Gap Up to $24.00Codexis (NASDAQ:CDXS) Shares Gap Up to $24.00
americanbankingnews.com - April 12 at 11:12 AM
Codexis, Inc. (NASDAQ:CDXS) Director Patrick Y. Yang Sells 20,000 SharesCodexis, Inc. (NASDAQ:CDXS) Director Patrick Y. Yang Sells 20,000 Shares
americanbankingnews.com - April 7 at 10:14 PM
Codexis Stock Shows Improving Market Leadership; Earns 83 RS Rating - Investors Business DailyCodexis Stock Shows Improving Market Leadership; Earns 83 RS Rating - Investor's Business Daily
investors.com - April 6 at 12:05 AM
Codexis Stock Shows Improving Market Leadership; Earns 83 RS RatingCodexis Stock Shows Improving Market Leadership; Earns 83 RS Rating
finance.yahoo.com - April 5 at 7:04 PM
Codexis (NASDAQ:CDXS) Sees Unusually-High Trading VolumeCodexis (NASDAQ:CDXS) Sees Unusually-High Trading Volume
americanbankingnews.com - April 1 at 12:08 PM
Codexis Sees IBD RS Rating Improve To 75 - Investors Business DailyCodexis Sees IBD RS Rating Improve To 75 - Investor's Business Daily
investors.com - March 31 at 12:56 PM
Codexis (NASDAQ:CDXS) Is In A Good Position To Deliver On Growth Plans - Yahoo FinanceCodexis (NASDAQ:CDXS) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
finance.yahoo.com - March 30 at 9:55 AM
Codexis (NASDAQ:CDXS) Is In A Good Position To Deliver On Growth PlansCodexis (NASDAQ:CDXS) Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com - March 30 at 9:55 AM
Insider Selling: Codexis, Inc. (NASDAQ:CDXS) Director Sells 10,000 Shares of StockInsider Selling: Codexis, Inc. (NASDAQ:CDXS) Director Sells 10,000 Shares of Stock
americanbankingnews.com - March 29 at 4:50 PM
CDXS Apr 2021 22.500 callCDXS Apr 2021 22.500 call
ca.finance.yahoo.com - March 22 at 1:02 PM
Codexis Getting Closer To Key Technical Benchmark - Investors Business DailyCodexis Getting Closer To Key Technical Benchmark - Investor's Business Daily
investors.com - March 10 at 8:13 PM
Benzingas Top Ratings Upgrades, Downgrades For March 1, 2021Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2021
finance.yahoo.com - March 9 at 8:56 AM
Codexis Shows Market Leadership With Jump To 83 RS Rating - Investors Business DailyCodexis Shows Market Leadership With Jump To 83 RS Rating - Investor's Business Daily
investors.com - March 3 at 5:15 PM
Global Proteinase K Market Analysis Report 2020-2027 Featuring Key players - Merck, BBI Solutions, Codexis, SBS Genetech, Hoffmann-La Roche, Amicogen Amano Enzyme & Advanced Enzymes Technologies - ResearchAndMarkets.com - Business WireGlobal Proteinase K Market Analysis Report 2020-2027 Featuring Key players - Merck, BBI Solutions, Codexis, SBS Genetech, Hoffmann-La Roche, Amicogen Amano Enzyme & Advanced Enzymes Technologies - ResearchAndMarkets.com - Business Wire
businesswire.com - March 1 at 12:36 PM
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Analysts Are Cutting Their Estimates: Heres What You Need To Know - NasdaqApellis Pharmaceuticals, Inc. (NASDAQ:APLS) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Nasdaq
nasdaq.com - March 1 at 7:36 AM
Cogent Communications Holdings, Inc. Just Missed Earnings - But Analysts Have Updated Their Models - NasdaqCogent Communications Holdings, Inc. Just Missed Earnings - But Analysts Have Updated Their Models - Nasdaq
nasdaq.com - February 28 at 8:02 PM
Codexis, Inc.s (CDXS) CEO John Nicols on Q4 2020 Results - Earnings Call Transcript - Seeking AlphaCodexis, Inc.'s (CDXS) CEO John Nicols on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - February 28 at 3:01 PM
Codexis, Inc. (NASDAQ:CDXS) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock? - NasdaqCodexis, Inc. (NASDAQ:CDXS) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock? - Nasdaq
nasdaq.com - February 28 at 10:01 AM
Codexis: Q4 Earnings Insights - Yahoo FinanceCodexis: Q4 Earnings Insights - Yahoo Finance
finance.yahoo.com - February 26 at 5:16 AM
Codexis: Q4 Earnings InsightsCodexis: Q4 Earnings Insights
finance.yahoo.com - February 25 at 10:51 PM
Codexis, Inc. to Host Earnings Call - Yahoo FinanceCodexis, Inc. to Host Earnings Call - Yahoo Finance
finance.yahoo.com - February 25 at 5:49 PM
Codexis Reports Fourth Quarter and Fiscal Year 2020 Financial Results - GlobeNewswireCodexis Reports Fourth Quarter and Fiscal Year 2020 Financial Results - GlobeNewswire
globenewswire.com - February 25 at 5:49 PM
Codexis Reports Fourth Quarter and Fiscal Year 2020 Financial ResultsCodexis Reports Fourth Quarter and Fiscal Year 2020 Financial Results
finance.yahoo.com - February 25 at 5:49 PM
Codexis to Present at Upcoming Virtual Healthcare Conferences - Yahoo FinanceCodexis to Present at Upcoming Virtual Healthcare Conferences - Yahoo Finance
finance.yahoo.com - February 18 at 7:46 PM
Codexis to Present at Upcoming Virtual Healthcare ConferencesCodexis to Present at Upcoming Virtual Healthcare Conferences
finance.yahoo.com - February 18 at 7:46 PM
Specialty Enzymes Market size to Reach USD 8.21 Billion by 2028 | Cost-Effective and Eco-Friendly Aspects of Specialty Enzymes is Driving Industry Growth, says Emergen Research - Yahoo Finance AustraliaSpecialty Enzymes Market size to Reach USD 8.21 Billion by 2028 | Cost-Effective and Eco-Friendly Aspects of Specialty Enzymes is Driving Industry Growth, says Emergen Research - Yahoo Finance Australia
finance.yahoo.com - February 17 at 8:31 AM
Codexis (CDXS) is Roubaix Capital’s Star Performer During the Q4 of 2020 - Yahoo FinanceCodexis (CDXS) is Roubaix Capital’s Star Performer During the Q4 of 2020 - Yahoo Finance
finance.yahoo.com - February 16 at 9:23 AM
Is Now The Time To Look At Buying Codexis, Inc. (NASDAQ:CDXS)? - Yahoo FinanceIs Now The Time To Look At Buying Codexis, Inc. (NASDAQ:CDXS)? - Yahoo Finance
finance.yahoo.com - February 13 at 11:46 PM
Is Now The Time To Look At Buying Codexis, Inc. (NASDAQ:CDXS)?Is Now The Time To Look At Buying Codexis, Inc. (NASDAQ:CDXS)?
finance.yahoo.com - February 13 at 8:44 AM
Alexandria District in San Carlos signs two new tenants - San Francisco Business TimesAlexandria District in San Carlos signs two new tenants - San Francisco Business Times
bizjournals.com - February 11 at 7:46 PM
Codexis to Report Fourth Quarter and Full Year 2020 Results on February 25 - Yahoo FinanceCodexis to Report Fourth Quarter and Full Year 2020 Results on February 25 - Yahoo Finance
finance.yahoo.com - February 11 at 7:46 PM
Codexis Announces Expansion to New Facility to Accommodate Next Stage of Growth - GlobeNewswireCodexis Announces Expansion to New Facility to Accommodate Next Stage of Growth - GlobeNewswire
globenewswire.com - February 11 at 9:45 AM
Codexis Announces Expansion to New Facility to Accommodate Next Stage of Growth - Yahoo Finance AustraliaCodexis Announces Expansion to New Facility to Accommodate Next Stage of Growth - Yahoo Finance Australia
finance.yahoo.com - February 9 at 8:21 PM
Codexis Appoints Dr. Esther Martinborough to its Board of Directors - Yahoo FinanceCodexis Appoints Dr. Esther Martinborough to its Board of Directors - Yahoo Finance
finance.yahoo.com - February 4 at 4:31 PM
Codexis Joins Elite Club Of Stocks With RS Ratings Over 90 - Investors Business DailyCodexis Joins Elite Club Of Stocks With RS Ratings Over 90 - Investor's Business Daily
investors.com - February 4 at 6:30 AM
Codexis Appoints Dr. Esther Martinborough to its Board of Directors - GlobeNewswireCodexis Appoints Dr. Esther Martinborough to its Board of Directors - GlobeNewswire
globenewswire.com - February 3 at 5:42 PM
Codexis Appoints Dr. Esther Martinborough to its Board of DirectorsCodexis Appoints Dr. Esther Martinborough to its Board of Directors
finance.yahoo.com - February 3 at 5:42 PM
At 21.9% CAGR, Synthetic Biology Market Size Expected to Reach 34.51 Bn by 2026 Says Brandessence Market Research - Yahoo FinanceAt 21.9% CAGR, Synthetic Biology Market Size Expected to Reach 34.51 Bn by 2026 Says Brandessence Market Research - Yahoo Finance
finance.yahoo.com - February 3 at 7:41 AM
Global Enzymes Market Outlook to 2027 - Featuring Sanofi, Roche Holding and Merck Among Others - ResearchAndMarkets.com - Yahoo FinanceGlobal Enzymes Market Outlook to 2027 - Featuring Sanofi, Roche Holding and Merck Among Others - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - February 2 at 10:02 AM
At 21.9% CAGR, Synthetic Biology Market Size Expected to Reach 34.51 Bn by 2026 Says Brandessence Market Research - GlobeNewswireAt 21.9% CAGR, Synthetic Biology Market Size Expected to Reach 34.51 Bn by 2026 Says Brandessence Market Research - GlobeNewswire
globenewswire.com - February 2 at 10:02 AM
Global Biocatalysis & Biocatalyst Market Report 2021 - ResearchAndMarkets.com - Business WireGlobal Biocatalysis & Biocatalyst Market Report 2021 - ResearchAndMarkets.com - Business Wire
businesswire.com - January 19 at 5:43 PM
Codexis Introduces Improved Enzymes to Further Enhance Tate & Lyles Stevia and Allulose Production - GlobeNewswireCodexis Introduces Improved Enzymes to Further Enhance Tate & Lyle's Stevia and Allulose Production - GlobeNewswire
globenewswire.com - January 13 at 11:27 AM
Codexis Inc.Codexis Inc.
barrons.com - January 10 at 5:05 PM
What Kind Of Investors Own Most Of Codexis, Inc. (NASDAQ:CDXS)? - Yahoo FinanceWhat Kind Of Investors Own Most Of Codexis, Inc. (NASDAQ:CDXS)? - Yahoo Finance
finance.yahoo.com - January 8 at 8:32 AM
This page was last updated on 4/20/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.